Skip to main content
Shop Plans Learn more about our coverage options including health, Medicare, dental and vision options for you, your family or your employees. Get Started Individual & Family Medicare Employer Vision Dental International Travel Find Care FAQ Blog Members Stay on top of your health care with helpful member resources. Members Home Medicare Health Dental Vision Find Care Member Knowledge Center Member Forms Medicare Forms Library Make a Payment Federal Employees Student Blue Healthy Blue Providers Access tools, policies and the latest information to help you care for our members. Providers Home Network Participation Networks & Programs Claims, Appeals & Inquiries Prior Authorization Services & CPT codes Prescription Drug Search Forms and Documents Policies, Guidelines & Codes Provider News Provider FAQ Contact Us Employers Learn about our coverage options for small and large employers, and access tools and resources for your group. Employers Home Shop Employer Plans Employer Portal Support Member Forms & Resources Find Care Blog Agents Access the tools you need: rate quotes, applications, forms, the latest industry news, marketing materials and more. Agents Home Agent Services Check Eligibility Find Care Member Forms & Resources Medicare Forms Library
Contact Us
Log In
I am ... Please select A member A provider An employer An agent
Log in to Agent Services
Log in to Employer Services Register for Employer Services I'm registered but need portal access
Username Forgot username? Continue to Log In Register for the member portal Need help? Learn how to log in.
Log in to Blue e Register for Blue e Log in to Dental Blue
Blue Cross NC Home Providers Policies, guidelines and codes Commercial Medical Policy Update June 10, 2026 Commercial Medical Policy Update June 10, 2026

 

Medical GuidelinesReason for Update
Automated Percutaneous and Endoscopic DiscectomyArchived medical policies have been removed from the Related Policies section.  References updated.  Specialty Matched Consultant Advisory Panel review 5/2026. Medical Director review 5/2026.  
Beta Amyloid Imaging with Positron Emission Tomography for Alzheimer’s DiseaseSpecialty Matched Consultant Advisory Panel review 5/2026. Medical Director review 5/2026. Policy archived.
BioZorb®References updated. Specialty Matched Consultant Panel review 5/2026. Medical Director review 5/2026.
Brachytherapy, Intracavitary Balloon Catheter for Brain CancerDescription, Policy Guidelines and References updated. No change to policy statement. Specialty Matched Consultant Advisory Panel review 5/2026. Medical Director review 5/2026.
Chemoembolization of the Hepatic Artery, Transcatheter ApproachDescription and Policy Guidelines updated. References added. Specialty Matched Consultant Advisory Panel review 5/2026. Medical Director review 5/2026. No change to policy statement.
Cranial Electrotherapy Stimulation (CES) and Auricular ElectrostimulationPolicy Guidelines update without change of policy intent. Regulatory Status and References updated.  Specialty Matched Consultant Advisory Panel review 5/2026.  Medical Director review 5/2026.  
Electronic Brachytherapy for Nonmelanoma Skin CancerDescription, Policy Guidelines and References updated. Code 0394T removed from Billing/Coding section. Specialty Matched Consultant Advisory Panel review 5/2026. Medical Director review 5/2026.
Endovascular Procedures for Intracranial Arterial DiseaseFormatting changes made to the “When Covered” section without change to policy intent. References updated.  Specialty Matched Consultant Advisory Panel review 5/2026. Medical Director review 5/2026.   
Image-Guided Minimally Invasive Decompression (IG-MLD) for Spinal StenosisReferences updated.  Specialty Matched Consultant Advisory Panel review 5/2026. Medical Director review 5/2026.  
Intensity Modulated Radiation Therapy for Tumors of the Central Nervous SystemReferences updated. Specialty Matched Consultant Advisory Panel review 5/2026. Medical Director review 5/2026.
Intensity Modulated Radiation Therapy (IMRT) for Sarcoma of the ExtremitiesReferences updated. Specialty Matched Consultant Advisory Panel review 5/2026. Medical Director review 5/2026.
Intensity Modulated Radiation Therapy (IMRT) of Abdomen and Pelvis  Description, Policy Guidelines and References updated. Updates to When Covered section: changed “Patients” to “Individuals”, added coverage criteria o. Seminoma. Removed testicular cancer from the statement in the Not Covered section which now reads “Intensity-modulated radiation therapy (IMRT) is considered not medically necessary for all other uses in the abdomen and pelvis.” Specialty Matched Consultant Advisory Panel review 5/2026. Medical Director review 5/2026.
Intensity Modulated Radiation Therapy (IMRT) of Head and NeckDescription section edited for clarity, References updated. Specialty Matched Consultant Advisory Panel review 5/2026. Medical Director review 5/2026.
Intensity Modulated Radiation Therapy (IMRT) of the ChestDescription section edited for clarity, References updated. Specialty Matched Consultant Advisory Panel review 5/2026. Medical Director review 5/2026.
Intensity Modulated Radiation Therapy (IMRT) of the ProstateDescription, Policy Guidelines and References updated. When Covered section edited to replace “patient” with “individual” throughout. No change to policy statement. Specialty Matched Consultant Advisory Panel review 5/2026. Medical Director review 5/2026. (tm)
Interspinous and Interlaminar Stabilization/Distraction Devices (Spacers)Description section revised.  References updated.  Medical Director review 5/2026.  Specialty Matched Consultant Advisory Panel review 5/2026.
Interspinous Fixation (Fusion) DevicesPolicy Guidelines updated without change to policy intent.  Added CPT code 22899 to the Billing/Coding section.  References updated.  Medical Director review 5/2026.  Specialty Matched Consultant Advisory Panel review 5/2026.
Intraoperative Neurophysiologic MonitoringPolicy Guidelines updated without change to policy intent.  References updated.  Medical Director review 5/2026.  Specialty Matched Consultant Advisory Panel review 5/2026. 
Magnetic Resonance SpectroscopyDescription updated. References added. Specialty Matched Consultant Advisory Panel review 5/2026. Medical Director Review 5/2026.  No change to policy statement.
MRI-Guided Focused Ultrasound (MRgFUS)Description, Regulatory Status, and Policy Guidelines updated. References added. Specialty Matched Consultant Advisory Panel review 5/2026. Medical Director review 5/2026. No change to policy statement.
Myocardial Sympathetic Innervation ImagingReferences added. Description updated.  Specialty Matched Consultant Advisory Panel review 5/2026.  Medical Director review 5/2026. No change to policy statement.
Occipital Nerve StimulationReferences updated.  Medical Director review 5/2026.  Specialty Matched Consultant Advisory Panel review 5/2026. 
Ovarian and Internal Iliac Vein Embolization, Ablation and SclerotherapyUpdated Description to remove “This policy does not address isolated treatment of male gonadal veins or varicose veins of the lower extremities. Refer to policy titled “Varicose Veins of the Lower Extremities, Treatment for.”
Percutaneous Electrical Nerve Stimulation (PENS), Percutaneous Neuromodulation Therapy, Restorative Neurostimulation Therapy, and Percutaneous Electrical Nerve Field Stimulation (PENFS)Policy title changed to “Percutaneous Electrical Nerve Stimulation (PENS), Percutaneous Neuromodulation Therapy, Restorative Neurostimulation Therapy, and Percutaneous Electrical Nerve Field Stimulation (PENFS).” Added the following policy statement: “Restorative neurostimulation therapy (ReActiv8) is considered investigational for all applications. BCBSNC does not provide coverage for investigational services or procedures.” Description, regulatory status, and policy guidelines updated. References added. Billing/Coding section updated to add 64555, 64585, 64596, 64597, 95970, 95971, 95972, C1767, and C9807, and to remove “Providers may submit claims for these services using the unlisted code 64999. Providers should not be using 64553-64565, or 64590 to bill this service as these codes are not appropriate.” Medical Director review 6/2026. No change to policy statement.
Perirectal Spacer Use During Radiotherapy for Prostate CancerDescription, Policy Guidelines and References updated. Specialty Matched Consultant Panel review 5/2026. Medical Director review 5/2026.
Positional Magnetic Resonance Imaging (MRI)References added. Specialty Matched Consultant Advisory Panel review 5/2026. Medical Director review 5/2026. No change in policy statement. 
Proton Beam TherapyCoverage criteria b. under the When Covered section edited to replace “patients” with “individuals”. Added new coverage criteria i. under When Covered section which reads “Localized tumors associated with genetic syndromes (i.e., Neurofibromatosis type 1, [NF-1], Li-Fraumeni, Ataxia Telangiectasia [with deleterious ATM mutations], Hereditary Retinoblastoma, Lynch syndrome, or Hereditary Breast or Ovarian Cancer [with BRCA1/2 mutations]).” References updated. Specialty Matched Consultant Advisory Panel review 5/2026. Medical Director review 5/2026.
Radioembolization for Primary and Metastatic Tumors of the LiverDescription, Policy Guidelines and References updated. When Covered section edited to replace “patients” with “individuals” for clarity, no change to policy statement. Specialty Matched Consultant Advisory Panel review 5/2026. Medical Director review 5/2026.
Radiosurgery, Stereotactic ApproachDescription and References updated. Minor editing to the When Covered and Policy Guidelines sections for clarity. No change to policy statement, Specialty Matched Consultant Advisory Panel review 5/2026. Medical Director review 5/2026.
Screening for Vertebral Fracture with Dual X-ray Absorptiometry (DXA)Description updated. References added. Specialty Matched Consultant Advisory Panel review 5/2026. Medical Director review 5/2026. No change to policy statement. 
Surgical Deactivation of Headache Trigger SitesReferences updated. Medical Director review 5/2026.  Specialty Matched Consultant Advisory Panel review 5/2026. 
Therapeutic Radiopharmaceuticals in OncologyReferences added. Specialty Matched Consultant Advisory Panel review 5/2026. Medical Director review 5/2026. No change to policy statement.
Vagus Nerve StimulationRegulatory Status and Policy Guidelines sections updated. No change to intent of policy.  Added the following HCPCS code to the Billing/Coding section: C1827. References updated.   Medical Director review 5/2026.  Specialty Matched Consultant Advisory Panel review 5/2026. 
Varicose Veins of the Lower Extremities, Treatment forUpdated note in Description section to remove the word “Gonadal.”  Updated Related Policies to correct title from “Ovarian, Internal Iliac and Gonadal Vein Embolization, Ablation and Sclerotherapy” to “Ovarian and Internal Iliac Vein Embolization, Ablation and Sclerotherapy.”
Whole Body Computed Tomography Scan as a Screening TestReferences added. Specialty Matched Consultant Advisory Panel review 5/2026. Medical Director review 5/2026. No change to policy statement.

 

About Us Newsroom Blog Member Forms Transparency in Coverage Find Care Rights & Responsibilities Policies & Best Practices Privacy Policy Website User Agreement Fraud & Abuse Technical Information Contact Us Locations Careers Developers

Blue Cross and Blue Shield of North Carolina does not discriminate on the basis of race, color, national origin, sex, age or disability in its health programs and activities. Learn more about our non-discrimination policy and no-cost services available to you.

Information in other languages: Español   中文   Tiếng Việt   한국어   Français   العَرَبِيَّة   Hmoob   ру́сский   Tagalog   ગુજરાતી   ភាសាខ្មែរ   Deutsch   हिन्दी   ລາວ   日本語

© 2026 Blue Cross and Blue Shield of North Carolina. ®, SM Marks of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield plans. All other marks and names are property of their respective owners. Blue Cross and Blue Shield of North Carolina is an independent licensee of the Blue Cross and Blue Shield Association.